Phenylalanine derivatives

Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control

Novel Pharmaceutical

Benzamide mGluR5 positive allosteric modulators and methods of making and using same

Use of n-(2-aryl-propionyl)-sulfonamides for the treatment of spinal cord injury

Sugar-coated preparation

Combined pharmaceutical preparation for treatment of type 2 diabetes

METHODS AND COMPOSITIONS FOR TREATING CARDIAC DYSFUNCTIONS

Agents for promoting the proliferation or differentiation of stem cells or neural progenitor cells

Methods for treatment prostate cancer using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione

Methods for treating head or neck cancer using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione

Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione

Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroindol-2-yl)-piperidine-2,6-dione follow by autologous stem cell transplantation

Methods for treating sarcoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione or 4-(amino)-2-(2,6 dioxo(3-piperidyl))-isoindoline-1,3-dione

Substituted phenols as active agents inhibiting VEGF production

SULFONYLTRYPTOPHANOLS

Methods of using (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4- acetylaminoisoindoline-1,3-dione

Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof

Methods and compounds for inhibiting amyloid deposits

Pharmaceutically active isoindoline derivates

Methods for treating brain cancer using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione or 4-(amino)-2-(2,6 dioxo(3-piperidyl))-isoindoline-1,3-dione

Methods for treatment of behcet's disease using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione

Use of Mglur5 (Esp. Afq056) in Gi (Esp.Gerd)

Methods of using (+)-2-[1-(3-ethoxy-4 methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione

Method for treatment and management of thyroid cancer using immunomodulatory compounds

Remedy for Angiospasm Accompanying Subarachnoid Hemorrhage Containing Thrombin Receptor Antagonist as the Active Ingredient

Organic compounds

Compounds

Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disordersB

Bechet's disease using cyclopropyl-N-carboxamide

SELECTIVE INHIBITION OF MATRIX METALLOPROTEINASES

Methods for the treatment of atherosclerosis, using substituted phenethylsulfones

ANTIALLERGIC AGENTS

Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinease Inhibitors

Methods of using(+)-2-[1-(3-ethoxy-4methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3,-dione

ω-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitors

Pharmaceutical composition for treatment of lipid metabolism disorder

Methods for treatment of ovarian, colorectal or pancreatic cancer using 4-(aminno)-2(2,6-dioxo(3-piperidyl)-isoindoline-1,3-dione

Analogs of thalidomide as potential angiogenesis inhibitors

Intracellular kinase inhibitors

PHARMACEUTICAL COMPOSITIONS CONTAINING A HYPOGLYCEMIC AGENT(S) FOR IMPROVING OR TREATING IMPAIRED GLUCOSE TOLERANCE, BORDERLINE DIABETES, INSULIN RESISTANCE OR HYPERINSULINEMIA

Preventive and/or Therapeutic Agents for Meniere's Disease

Vascular endothelial receptor specific inhibitors

Methods for treatment, modification and management of radiculopathy using 1-oxo-2-(2,6-dioxopiperidin-3yl)-4-aminoisoindoline

Methods for preventing and/or treating a cell proliferative disorder

Composition containing benzamidine derivative and method for stabilizing benzamidine derivative

Combination of A 5-HT(1) Receptor Agonist and an Alpha-2-Delta Ligand for the Treatment of Migraine

Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of disorders of the central nervous system

Antiallergic agents

Antiallergic agents

COMBINATIONS OF METFORMIN AND A MEGLITINIDE

C-glycoside derivatives and salts thereof

Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain

Chlorthalidone combinations

Methods for treating cutaneous lupus using aminoisoindoline compounds

Therapeutic inhibitor of vascular smooth muscle cells

Therapeutic inhibitor of vascular smooth muscle cells

Benzene compounds

Method of inhibiting neurotrophin-receptor binding

Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses

Novel method of treatment of inflammatory skin conditions

Immunological uses of immunomodulatory compounds for vaccine and anti-infectious disease therapy

Methods and composition for inhibition of angiogenesis

N-aryl-2-oxazolidinone-5-carboxamides and their derivatives

NPY Y5 antagonist

Method of treating hypertension with a very low dose of chlorthalidone

Method of lowering intraocular pressure

Beta-sheet mimetics and methods relating to the use thereof

β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins

Sod minic multifunctional compounds for treating inflammatory bowel disease

Formulation for inwardly transferring nucleic acids into eucaryotic cells

Methods of using and compositions comprising (+)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide

Methods of the treatment or prevention of exercise-induced asthma using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione

Methods of the treatment of psoriatic arthritis using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione

Methods for treatment and management of lung cancer using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione

Methods and compositions using immunomodulatory compounds for treatment and management of parasitic diseases

Methods of using and compositions comprising PDE4 modulators for treatment, prevention and management airway inflammation

Method for the treatment of myelodysplastic syndromes using cyclopropanecarboxylic acid {2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-OXO-2,3-dihydro-1 H-isoindol-4-yl}-amide

Use of pagoclone for the treatment of social anxiety disorder

Antiallergic

C-glycoside derivatives and salts thereof

Medicament for treatment of diabetes

Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient

Methods and compositions using PDE4 modulators for treatment and management of central nervous system injury

Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases

Inhibitors against the activation of ap-1 and nfat

Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases

Cb 1/cb 2 receptor ligands and their use in the treatment of pain

Methods for treatment of chronic uveitis using cyclopropyl-n-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide

Prevention and treatment of cardiovascular pathologies

Inhibitors of the S100-p53 protein-protein interaction and method of inhibiting cancer employing the same

Methods for treatment of atherosclerosis using 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline

Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione

Drug composition for blood sugar control

Methods for preserving tissue

Methods of using and compositions comprising PDE4 modulators for the treatment and management of pulmonary hypertension

Antibacterial compositions comprising metal phthalocyanine analogues

Methods for treatment of multiple myeloma using cyclopropane carboxylic acid {2-[(is)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1 h-isoindol-4-yl}-amide

Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders

Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient

Methods for inhibiting undesired angiogenesis in patients having tumors with thalidomide

Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain

(+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione:, and methods of synthesis and compositions thereof

Methods for treatment of cancers using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione

Methods of using and compositions comprising PDE4 modulators for the treatment and management of asbestos-related diseases and disorders

Use of small molecule compounds for immunopotentiation

Process for preparing (3-oxo-2,3-dihydro-1H-isoindol-1-yl) acetylguanidine derivatives

Development of novel regulators of angiogenesis

Solid compositions containing compounds unstable to oxygen and method for stabilization thereof

Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxygenase-1

Use of endothelin receptor antogonists for the treatment of tumour diseases

Methods and compositions for treating an ocular neovascular disease

Method of treating cancer with a selenide

Method of treating cancer in a subject

Compositions of autophagy modulating agents and uses thereof

Crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione monohydrate, compositions and methods of use thereof

Crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione dihydrate, compositions and methods of use thereof

Dual PPAR-δ PPAR-γ agonists